LIPOPROTEIN ABNORMALITIES IN HYPERTRIGLYCERIDEMIC PATIENTS ON LONG-TERM HEMODIALYSIS

被引:2
作者
ZAMBON, S [1 ]
ZAMBON, A [1 ]
STABELLINI, N [1 ]
TARRONI, G [1 ]
GILLI, P [1 ]
CREPALDI, G [1 ]
MANZATO, E [1 ]
机构
[1] ST ANNAS HOSP,DIV NEPHROL,FERRARA,ITALY
关键词
CARDIOVASCULAR DISEASE; CHOLESTEROL; HEMODIALYSIS; LIPOPROTEINS; TRIGLYCERIDES;
D O I
10.1111/j.1365-2796.1993.tb00733.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To analyse by ultracentrifugation in a zonal rotor the plasma lipoproteins in hypertriglyceridaemic patients on long-term haemodialysis. Design. Case-control study. Setting. Tertiary referred care centre. Subjects. Ten consecutive hypertriglyceridaemic patients on haemodialysis and 12 consecutive healthy controls. Main outcome measures. Plasma lipid and lipoprotein cholesterol concentrations, lipoprotein physical properties and compositions, apolipoprotein concentrations. Results. Hypertriglycerldaemia in patients undergoing haemodialysis is characterized by an increased amount of small and slow floating very-low density lipoproteins (VLDL), higher concentrations of intermediate density lipoproteins (IDL) and small and dense low-density lipoprotein (LDL) particles; reduced levels of high-density lipoproteins (HDL), in particular of HDL2. The lipoprotein composition of such patients indicates reduced cholesterol ester and increased triglyceride content. Compared to controls, they have lower levels of plasma apolipoprotein A-I and A-II and higher B, C-II, C-III and E values. Conclusions. The lipoprotein abnormalities observed in hypertriglyceridaemic patients undergoing haemodialysis have recently been associated with an increased incidence of vascular complications and may in part explain the high incidence of vascular disease reported in these subjects.
引用
收藏
页码:217 / 221
页数:5
相关论文
共 34 条
[1]   ANOMALIES IN COMPOSITION OF UREMIC LIPOPROTEINS ISOLATED BY GRADIENT ULTRACENTRIFUGATION - RELATIVE ENRICHMENT OF HDL IN APOLIPOPROTEIN C-III AT THE EXPENSE OF APOLIPOPROTEIN A-I [J].
ATGER, V ;
DUVAL, F ;
FROMMHERZ, K ;
DRUEKE, T ;
LACOUR, B .
ATHEROSCLEROSIS, 1988, 74 (1-2) :75-83
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1817
[3]   SERUM APOLIPOPROTEIN PROFILE OF HYPERTRIGLYCERIDEMIC PATIENTS WITH CHRONIC RENAL-FAILURE ON HEMODIALYSIS - A COMPARISON WITH TYPE-IV HYPERLIPOPROTEINEMIC PATIENTS [J].
AVERNA, MR ;
BARBAGALLO, CM ;
GALIONE, A ;
CARROCCIO, A ;
LABISI, M ;
MARINO, G ;
MONTALTO, G ;
NOTARBARTOLO, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07) :601-602
[4]   PLASMA HIGH-DENSITY LIPOPROTEIN CONCENTRATIONS IN CHRONIC-HEMODIALYSIS AND RENAL-TRANSPLANT PATIENTS [J].
BAGDADE, JD ;
ALBERS, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (25) :1436-1439
[5]   PREVALENCE OF SERUM-LIPID ABNORMALITIES IN CHRONIC-HEMODIALYSIS [J].
BRUNZELL, JD ;
ALBERS, JJ ;
HAAS, LB ;
GOLDBERG, AP ;
AGADOA, L ;
SHERRARD, DJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (08) :903-910
[6]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[7]   PATHOGENIC ROLES OF POST-HEPARIN LIPASES IN LIPID ABNORMALITIES IN HEMODIALYSIS-PATIENTS [J].
CHAN, MK ;
PERSAUD, J ;
VARGHESE, Z ;
MOORHEAD, JF .
KIDNEY INTERNATIONAL, 1984, 25 (05) :812-818
[8]  
DUVAL F, 1989, CLIN CHEM, V35, P963
[9]   MANAGEMENT OF HYPERLIPIDEMIA OF KIDNEY-DISEASE [J].
GRUNDY, SM .
KIDNEY INTERNATIONAL, 1990, 37 (03) :847-853
[10]   APOPROTEIN A-I AND HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH CHRONIC RENAL-FAILURE RECEIVING HEMODIALYSIS [J].
JOVEN, J ;
RUBIESPRAT, J ;
ESPINEL, E ;
CHACON, P ;
OLMOS, A ;
MASDEU, S .
NEPHRON, 1985, 40 (04) :451-454